Articles tagged with "healthcare-innovation"
Microbot Medical closes stock sale with $29.2M raised - The Robot Report
Microbot Medical Inc., a company specializing in advanced robotic technology for endovascular procedures, has completed the final closing of its stock option exercise, raising $29.2 million by selling 13.9 million shares of common stock. Founded in 2010 and based in Hingham, Massachusetts, Microbot offers the LIBERTY Endovascular Robotic System, a single-use, remotely operated device designed to improve precision, safety, and efficiency in neurovascular, cardiovascular, and peripheral vascular procedures. The system’s compact, single-use design enables controlled remote operation, potentially lowering procedure costs and enhancing care quality. In addition to the stock sale, Microbot announced a new patent for a modular robotic surgical system featuring a base and multiple interchangeable tool-receiver units, which could broaden LIBERTY’s applicability across various endovascular procedures. The company has issued new short-term Series J preferred investment options with an exercise price of $4.50 per share, potentially raising up to $63 million if fully exercised.
roboticssurgical-robotsmedical-technologyrobotic-surgeryhealthcare-innovationendovascular-proceduresMicrobot-MedicalHistoSonics reaches $2.25B valuation after investor-led majority acquisition - The Robot Report
HistoSonics, a medical technology company specializing in non-invasive tumor treatment using histotripsy, has reached a valuation of approximately $2.25 billion following a management-led majority acquisition by a syndicate of private and public investors, including K5 Global, Bezos Expeditions, and Wellington Management. The company’s flagship product, the Edison System, delivers pulsed sound energy to mechanically destroy tumors without incisions or needles. With FDA de novo clearance granted in October 2023, Edison has treated over 2,000 patients across more than 50 U.S. medical centers, with plans for further installations and expanded market access, including limited approval in the U.K. The new investment will enable HistoSonics to accelerate growth and broaden the clinical applications of its technology beyond liver tumors to include kidney, pancreas, and prostate indications. The company is actively enrolling patients in clinical trials for these conditions and aims to extend histotripsy’s use to treat a wide range of benign and malignant
robotmedical-roboticsultrasound-technologyhistotripsynon-invasive-therapyhealthcare-innovationtumor-treatmentSwan EndoSurgical debuts to advance GI Robotics
Olympus has partnered with investment firm Revival Healthcare Capital to co-found Swan EndoSurgical, a new company focused on developing an advanced endoluminal robotic system for gastrointestinal (GI) patient care. The joint venture involves a potential investment of up to $458 million, with Revival holding a majority equity stake and Olympus maintaining significant participation and an option to acquire Swan at a predetermined value. This collaboration aims to enhance minimally invasive treatments by improving precision, efficiency, and ergonomics in GI procedures, building upon traditional endoscopy techniques used for early diagnosis and treatment of GI conditions such as cancer. The development of Swan EndoSurgical’s robotic system seeks to overcome the limitations of manual endoscopes by enabling flexible maneuvering and deployment of robotic arms within the GI tract, potentially allowing safer, more effective surgeries that avoid invasive methods. The company has already established an experienced leadership team and will be headquartered in the U.S. Olympus views this partnership as a strategic milestone to reshape the GI market by expanding procedural
roboticssurgical-roboticsmedical-technologyendoluminal-roboticshealthcare-innovationminimally-invasive-surgerygastrointestinal-roboticsSS Innovations completes intercontinental robotic cardiac telesurgery with SSi Mantra - The Robot Report
SS Innovations International announced a groundbreaking intercontinental robotic cardiac telesurgery performed on July 19, 2025. Dr. Sudhir Srivastava, CEO and Chairman, remotely operated the company’s SSi Mantra 3 surgical robotic system from Strasbourg, France, to conduct an atrial septal defect closure on a patient located 4,000 miles away at the Sri Aurobindo Institute of Medical Sciences (SAIMS) in Indore, India. The surgery, completed during the Society of Robotic Surgery (SRS) Annual Meeting, was executed without technical issues, demonstrating imperceptible latency and high precision. This achievement highlights the advanced capabilities of the SSi Mantra 3 system and represents a significant step toward expanding access to complex cardiac care globally, particularly in regions lacking surgical expertise. SS Innovations, based in Fort Lauderdale, Florida, has been advancing robotic telesurgery technology to make it more affordable and accessible worldwide. The company’s product line includes the SSi Mantra
roboticstelesurgerymedical-robotsrobotic-surgeryremote-surgerysurgical-technologyhealthcare-innovationDistalmotion makes its first multirobot sale in the U.S. - The Robot Report
Distalmotion has achieved its first multirobot sale in the U.S. with AdventHealth, a large healthcare system operating 50 hospitals across nine states, adopting its DEXTER robotic surgery system to expand minimally invasive procedures. AdventHealth has already completed initial surgeries using DEXTER in its outpatient department, highlighting the system’s alignment with goals for flexibility and efficiency. The DEXTER system, developed by the Lausanne-based company with U.S. offices in Cleveland, is commercially available in both the U.S. and Europe and is designed to simplify operations and broaden access to robotic surgery, particularly in outpatient hospital departments and ambulatory surgical centers. The DEXTER robot addresses the rising demand for surgical robotics in high-volume soft-tissue procedures moving to outpatient settings by offering a mobile, compact, and quickly deployable system that integrates easily into existing workflows. Unique features include a sterile console that allows surgeons to perform bedside tasks without breaking sterility or redocking, and an open architecture compatible with existing instruments
roboticssurgical-robotsmedical-technologyhealthcare-innovationrobotic-surgeryminimally-invasive-surgeryhospital-technologyHistoSonics Edison system gains early market access in the U.K. - The Robot Report
robotultrasoundhistotripsymedical-technologynon-invasive-treatmentliver-tumorshealthcare-innovationJ&J reports positive Monarch robotic bronchoscopy data - The Robot Report
robotrobotic-surgerybronchoscopymedical-technologyminimally-invasive-proceduresJohnson-&-Johnsonhealthcare-innovationMicrorobot system is designed to float inside stroke patient for autonomous thrombectomy - The Robot Report
robotthrombectomymicrorobotmedical-technologyautonomous-systemsdigital-twinhealthcare-innovation